M. Kirchner - Pathologisches Institut, Universitätsklinikum Heidelberg

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 32 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

54P Efficacy of first-line immunotherapy for non-small cell lung cancer with MET exon 14 skipping according to PD-L1 expression

M. Blasi,J.B. Kuon,H. Lüders,D. Misch,D. Kauffmann-Guerrero, M. Hilbrandt,D. Kazdal, R.F. Falkenstern-Ge,B. Hackanson,S. Dintner,M. Faehling,M. Kirchner,H-G. Kopp,M. Allgäuer,C. Grohe,A. Tufman,M. Reck,N. Frost,A. Stenzinger, M. Thomas,P. Christopoulos

ESMO Open (2024)

引用0浏览0引用

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)

E. Rempel,K. Kluck, S. Beck,I. Ourailidis,D. Kazdal,O. Neumann,A. L. Volckmar,M. Kirchner, H. Goldschmid,N. Pfarr,W. Weichert, D. Hübschmann,S. Fröhling,C. Sutter,C. P. Schaaf,P. Schirmacher,V. Endris,A. Stenzinger,J. Budczies

NPJ PRECISION ONCOLOGY（2022）

引用17浏览0WOSNATURE引用

Survival of Patients with advanced NSCLC on Immunotherapy based on Cytokine Profile in Serum

H. Schindler,F. Lusky,M. Elshiaty,F. Bozorgmehr,J. Kuon, R. Shah, M. Schneider,F. Eichhorn,A. Angeles,F. Janke,M. Kriegsmann,D. Kazdal,M. Kirchner,A. Stenzinger,H. Sultmann, M. Thomas,P. Christopoulos

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022)

引用0浏览0引用

EP08.01-031 Blood Gene Expression Changes in Metastatic Lung Cancer under Second-Line Immunotherapy According to Clinical Response

F. Lusky,H. Schindler,M. Elshiaty,L. Gaissmaier,L. Daniello,F. Bozorgmehr,J. Kuon,R. Shah,M. A. Schneider,F. Eichhorn,F. Trudzinski,A. Angeles,F. Janke,M. Kirchner,D. Kazdal,A. Stenzinger,H. Sultmann, M. Thomas,P. Christopoulos

Journal of thoracic oncologyno. 9 (2022): S351-S352

引用0浏览0引用

Off-label trastuzumab deruxtecan as salvage therapy for an elderly patient with refractory lung adenocarcinoma

C. Wiedemann,J. Kunz,M. Kirchner,C. -P Heussel,H. Grosch,H. Bischoff,M. Steins,A. Stenzinger, M. Thomas,P. Christopoulos

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Bilcap-Study: Should Patients With Resected Biliary Tract Cancer Really Receive Adjuvant Chemotherapy With Capecitabine

G. Manzini, U. Klotz,I. Hines,D. Henne-Bruns,M. Kremer,M. Kirchner

BRITISH JOURNAL OF SURGERY（2021）

引用0浏览0引用

The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma

M. Kirchner,K. Kluck, R. Brandt,A. -L. Volckmar,R. Penzel, D. Kazdalz,V. Endris,O. Neumann, H. Seker-Cin, H. Goldschmid,J. Glade, M. Allgaeuer,M. Kriegsmann,H. Winter,T. Muley, S. Pernerz, N. Frostx,M. Reck,S. Frohling,P. Schirmacher,M. Thomas, J. Budcziesy,P. Christopoulos,A. Stenzinger

ESMO openno. 5 (2021): 100253-100253

引用18浏览0WOS引用

Characterization of alectinib-induced hemolysis in three patients with ALK-rearranged lung cancer

J. Kunz,C. Wiedemann,H. Grosch,H. Bischoff,J. Kunz,K. Schlamp,K. Kriegsmann,A. Stenzinger,M. Kriegsmann, R. Brandt,M. Kirchner, M. Allgaeuer,P. Christopoulos, M. Thomas

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn